Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2019
Pharma News, 2019
Lilly cancer drug fails key trial, will no longer be prescribed
(Reuters) - Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and wil...
FDA recalls inspectors as shutdown drags on; Gottlieb calls PDUFA most 'vulnerable'
With the government shutdown now in its fourth week—the longest ever—FDA Commissioner Scott Gottlieb, M.
Pfizer partners with Medochemie to make drugs in Vietnam
Vietnam has transformed its economy from one of the world’s poorest to one that is comfortably middle income.
Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases
HANGZHOU, China and SHAOXING, China and SUZHOU, China, Jan.
Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma L.L.C. to Focus on New and Innovative Therapies for Cancer Patients
HENDERSON, Nev.
BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib in Mantle Cell Lymphoma
CAMBRIDGE, Mass.
Researchers Successfully Turn Breast Cancer Cells Into Fat to Stop Them From Spreading
Researchers have been able to coax human breast cancer cells to turn into fat cells in a new proof-of-concept study in mice.
Amgen's postmenopausal osteoporosis drug wins FDA panel backing
(Reuters) - An advisory panel to the U.
Walgreens and Microsoft partner to develop digital healthcare services
(Reuters) - Drugstore chain Walgreens Boots Alliance Inc and Microsoft Corp said on Tuesday they have entered a seven-year agreement to research and develop new methods of delivering healthcar...
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment
LONDON, Jan.
ASLAN Pharmaceuticals Announces Study Results from Phase 2 Study of Varlitinib in First-line Gastric Cancer
SINGAPORE, Jan.
Painless microneedle patch provides month-long contraception
Contraceptives are rarely convenient – implanted devices are invasive, and you have to remember to take the pill every day.
57
58
59
60
61
62
63
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds